InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Umstead John V.. Director active across 1 company, notably G1 Therapeutics, Inc.. Cumulatively, 2 disclosures have been recorded. History available since 15 March 2023. The latest transaction was filed on 10 May 2023 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
2 of 2 declarations